Navigation Links
Actinomyces Culture

ProductsActinomyces Culture
Company ARUP Laboratories
Item Actinomyces Culture
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Culture Incubator
2. Pathfinder Chlamydia Culture Confirmation Test
3. E. Coli Enrichment Culture Strip
4. E. Coli Enrichment Culture Cassette
5. Abscess Culture
6. Acanthamoeba Culture
7. Adenovirus Culture
8. AFB Culture (Includes AFB Stain 0060151)
9. AFB Culture, Blood
10. Anaerobe Culture (Includes Gram Stain 0060101)
11. Bartonella Culture
...lXpress™ kit provides a rapid method for the ...tent nucleic acids; however, the kit does not sepa...NA can be achieved by incubating the purified mate...lowed by re-extraction with ViralXpress™. The...
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution
The Titertek MAP-C2 is designed for high throughput microplate processing. The heart of the instrument is the S60 Stacker that handles up to 60 microplates in two removable magazines. The MAP-C2 base
...imeter 4000 provides a fast, accurate assessment o...eters patented,state-of-the-art optics yield acc...moglobin as well as total hemoglobin. When,used ...imeter,4000 gives a comprehensive and complete a...
Medicine Products:
(Date:10/13/2008)...cessation programs, along with referrals to cardia...reased rates of quitting smoking following heart a... issue of Archives of Internal Medicine, one of ...esearchers studied 639 patients who smoked at the ...x months later, 297 of the patients approximately...
(Date:10/13/2008)...RM THIS WINTER WITH THE VIPER RESPONDER LE SPECIAL...RT SYSTEM, VISTA, Calif., Oct. 13 /PRNewswire-Fir...bsidiary of DEI Holdings Inc. (Nasdaq: DEIX ), ha...availability of Responder LE,Special Edition 2-Way...r,supporting Susan G. Komen for the Cure. For eac...
(Date:10/13/2008)...were lower than Alzheimer,s patients, healthy cont...ws) -- Parkinson,s disease patients are more likel...ave vitamin D deficiency, say researchers from the..., They compared vitamin D levels in 100 Parkinso...thy people matched for age and other factors. ,...
(Date:10/13/2008)...ion dollar NIH funding advances study Study ...s, MINNEAPOLIS, Oct. 13 /PRNewswire/ -- Advanced ...culatory.com ) announced today that it has receive...ational Institutes of,Health (NIH) to continue a s...ose who experience cardiac arrest outside a hospit...
Breaking Medicine News(10 mins):Health News:Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month 2Health News:Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month 3Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2
...ers have successfully cured advanced melanoma skin...ells causing them to attack the cancer cells. // A...ute (NCI) have confirmed in their research that ar...t advanced melanoma, which is considered as the mo...
...al Research Council suggests that cancers like cer...the presence of a hormone in semen.// The research... the development of tumors. In a report in the Jou...uction, the researchers recommend that women havin...
... potential of growing by a whopping 25 percent ann...) a year by 2012, Tourism Minister Ambika Soni sai...d looking at the response from foreign patients, w...Rs.100 billion annually by 2012," said Soni while ...
...sumed lending to India's health sector with an app...rnment said Tuesday.// "Three projects totalling $...ar, have now been approved by the board of executi...ank," a finance ministry statement said. The appr...
Other Medicine News:Health News:Gene Therapy Used In Treating Cancer 2Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 2Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 3
(Date:10/10/2008)...nd MENLO PARK, Calif., Oct. 10 /PRNewswire-FirstCa...d that it plans to present,long-term follow-up dat...xt,week at the Cardiovascular Research Foundation,...lar Therapeutics (TCT) meeting in Washington, DC.,... designed to investigate,the safety and efficacy o...
(Date:10/10/2008)... Show Prophylaxis Treatment with Kogenate FS Reduc... Children with No Pre-Existing,Joint Damage, BERK...Care LLC,announced today that the U.S. Food and Dr...ylaxis with Kogenate(R) FS Antihemophilic Factor,(...pisodes and the risk of,joint damage in patients a...
(Date:10/10/2008)...., Oct. 10 /- Boston Scient... schedule of the Company,s major,events and press ...ation,s,(CRF) twentieth annual Transcatheter Cardi... which runs from October 12 to 17 in Washington, D...range of safety and,efficacy data on its TAXUS(R) ...
(Date:10/9/2008)...an Campaign to Spread Awareness and Bring Hope to .../PRNewswire-USNewswire/ -- 133 million children,ac...uses such as natural,disaster, civil war, and dise...rving World Orphan Week by calling attention to th...edia News Release, go to:, http://www.prnewswire...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Consistency Flexibility Key in Improving Rewards 26 Recognition Programs 7079 1Consistency Flexibility Key in Improving Rewards 26 Recognition Programs 7079 2Telik Announces Financial Results For 2008 Second Quarter 7076 1Telik Announces Financial Results For 2008 Second Quarter 7076 2Telik Announces Financial Results For 2008 Second Quarter 7076 3Telik Announces Financial Results For 2008 Second Quarter 7076 4Researchers Hunt Normal Cells That Give Rise to Cancer 25275 1Researchers Hunt Normal Cells That Give Rise to Cancer 25275 2Lack of Vitamin D Boosts Death Risk 25272 1Lack of Vitamin D Boosts Death Risk 25272 2Lack of Vitamin D Boosts Death Risk 25272 3
...Apr 23, 2007 - CytRx Corporation,(NASDAQ:CYTR) tod...very technology exclusively licensed to its majori...on (RXi), has been,published in the April 2007 iss...l Biology. The technology was developed by RXi,Co-...ersity of,Massachusetts Medical School (UMMS) Prof...
...PRNewswire/ -- Sirion Therapeutics,announced today...nds, ST-601 (difluprednate) and ST-602 (fenretinid...f The Association for,Research in Vision and Ophth... to these presentations, the company will be hosti...prednate) is currently being evaluated in two phas...
Other Medicine Technology:CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4